University of Chicago researchers developed an mRNA nanoparticle system that triggers cells to produce PD-L1 protein, ...

"It feels like glass running through your veins." Faith Adjei-Sarpong lives with sickle cell disease and, like many others ...

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across eight U.S. sites.

Accumulation of the protein tau in the brain is one of the hallmarks of Alzheimer's disease. In a paper published in Cell ...

Glucocorticoids and B-cell targeting therapies are the cornerstones of IgG4 disease treatment, according to data presented at ...

After more than a decade of research, scientists have discovered the natural mechanism behind a novel form of cell death ...

THE government has urged health professionals to intensify research efforts to address the growing challenge of rare diseases ...

When specialized cells called tanycytes stop working, disease-causing tau proteins build up in the brain. A group of specialized cells play a crucial part in clearing toxic proteins from inside the ...

Mitochondria are essential for cell survival, repair, and adaptation. Not only do they generate most of the energy needed ...

Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune ...

Scientists have identified prematurely aged astrocytes in the brains of Alzheimer’s patients, particularly those with the APOE4 risk gene. Their findings suggest that cellular senescence in these ...

BUFFALO, N.Y. (WIVB) — Local groups are raising awareness about sickle cell disease and encouraging people to roll up their sleeves and donate blood. Sickle cell disease is a genetic blood disorder ...